Literature DB >> 20152836

Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats.

Rodolphe Soret1, Julien Chevalier, Pierre De Coppet, Guillaume Poupeau, Pascal Derkinderen, Jean Pierre Segain, Michel Neunlist.   

Abstract

BACKGROUND & AIMS: Little is known about the environmental and nutritional regulation of the enteric nervous system (ENS), which controls gastrointestinal motility. Short-chain fatty acids (SCFAs) such as butyrate regulate colonic mucosa homeostasis and can modulate neuronal excitability. We investigated their effects on the ENS and colonic motility.
METHODS: Effects of butyrate on the ENS were studied in colons of rats given a resistant starch diet (RSD) or intracecal perfusion of SCFAs. Effects of butyrate were also studied in primary cultures of ENS. The neurochemical phenotype of the ENS was analyzed with antibodies against Hu, choline acetyltransferase (ChAT), and neuronal nitric oxide synthase (nNOS) and by quantitative polymerase chain reaction. Signaling pathways involved were analyzed by pharmacologic and molecular biology methods. Colonic motility was assessed in vivo and ex vivo.
RESULTS: In vivo and in vitro, RSD and butyrate significantly increased the proportion of ChAT- but not nNOS-immunoreactive myenteric neurons. Acetate and propionate did not reproduce the effects of butyrate. Enteric neurons expressed monocarboxylate transporter 2 (MCT2). Small interfering RNAs silenced MCT2 and prevented the increase in the proportion of ChAT- immunoreactive neurons induced by butyrate. Butyrate and trichostatin A increased histone H3 acetylation in enteric neurons. Effects of butyrate were prevented by inhibitors of the Src signaling pathway. RSD increased colonic transit, and butyrate increased the cholinergic-mediated colonic circular muscle contractile response ex vivo.
CONCLUSION: Butyrate or histone deacetylase inhibitors might be used, along with nutritional approaches, to treat various gastrointestinal motility disorders associated with inhibition of colonic transit. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152836     DOI: 10.1053/j.gastro.2010.01.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  148 in total

1.  The gut microbiota keeps enteric glial cells on the move; prospective roles of the gut epithelium and immune system.

Authors:  Panagiotis S Kabouridis; Reena Lasrado; Sarah McCallum; Song Hui Chng; Hugo J Snippert; Hans Clevers; Sven Pettersson; Vassilis Pachnis
Journal:  Gut Microbes       Date:  2015

2.  A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids.

Authors:  Xiaojiao Zheng; Yunping Qiu; Wei Zhong; Sarah Baxter; Mingming Su; Qiong Li; Guoxiang Xie; Brandon M Ore; Shanlei Qiao; Melanie D Spencer; Steven H Zeisel; Zhanxiang Zhou; Aihua Zhao; Wei Jia
Journal:  Metabolomics       Date:  2013-08-01       Impact factor: 4.290

Review 3.  Microbiome, Immunomodulation, and the Neuronal System.

Authors:  Eric Marietta; Irina Horwath; Veena Taneja
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 4.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

5.  High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy.

Authors:  Yvonne Nyavor; Catherine R Brands; George May; Sydney Kuther; Jessica Nicholson; Kathryn Tiger; Abigail Tesnohlidek; Allysha Yasuda; Kiefer Starks; Diana Litvinenko; David R Linden; Yogesh Bhattarai; Purna C Kashyap; Larry J Forney; Onesmo B Balemba
Journal:  Neurogastroenterol Motil       Date:  2020-03-13       Impact factor: 3.598

6.  Free fatty acid receptor 3 is a key target of short chain fatty acid. What is the impact on the sympathetic nervous system?

Authors:  Eduardo Javier López Soto; Luisina Ongaro Gambino; Emilio Román Mustafá
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

Review 7.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

8.  Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion.

Authors:  Yogesh Bhattarai; Brianna B Williams; Eric J Battaglioli; Weston R Whitaker; Lisa Till; Madhusudan Grover; David R Linden; Yasutada Akiba; Karunya K Kandimalla; Nicholas C Zachos; Jonathan D Kaunitz; Justin L Sonnenburg; Michael A Fischbach; Gianrico Farrugia; Purna C Kashyap
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

9.  Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut.

Authors:  Henrik M Roager; Lea B S Hansen; Martin I Bahl; Henrik L Frandsen; Vera Carvalho; Rikke J Gøbel; Marlene D Dalgaard; Damian R Plichta; Morten H Sparholt; Henrik Vestergaard; Torben Hansen; Thomas Sicheritz-Pontén; H Bjørn Nielsen; Oluf Pedersen; Lotte Lauritzen; Mette Kristensen; Ramneek Gupta; Tine R Licht
Journal:  Nat Microbiol       Date:  2016-06-27       Impact factor: 17.745

10.  Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial.

Authors:  G Bazzocchi; T Giovannini; C Giussani; P Brigidi; S Turroni
Journal:  Tech Coloproctol       Date:  2014-08-05       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.